XOMA Corporation (XOMA) financial statements (2020 and earlier)

Company profile

Business Address 2200 POWELL STREET
EMERYVILLE, CA 94608
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments574643266678122
Cash and cash equivalents574643266678102
Short-term investments    0 20
Receivables3101434
Other undisclosed current assets0001222
Total current assets:604844277284127
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment0001256
Other noncurrent assets0110111
Other undisclosed noncurrent assets3515     
Total noncurrent assets:361612368
TOTAL ASSETS:966445297590135
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2249132320
Accounts payable11267610
Accrued liabilities011211010
Employee-related liabilities100257 
Taxes payable  2    
Interest and dividends payable0 0000 
Deferred revenue2
Debt51 186196
Deferred revenue and credits21312
Contract with customer, liability1
Other undisclosed current liabilities02141(7)2
Total current liabilities:96733233630
Noncurrent Liabilities
Long-term debt and lease obligation28221525431635
Long-term debt, excluding current maturities27221525431635
Capital lease obligations   0  
Operating lease, liability0
Liabilities, other than long-term debt1511718124
Deferred revenue and credits1718 24
Deferred revenue15
Other liabilities01001  
Other undisclosed noncurrent liabilities 17  103270
Total noncurrent liabilities:433932435450109
Total liabilities:524539767787139
Stockholders' equity
Stockholders' equity attributable to parent, including:44196(47)(2)3(4)
Common stock0000111
Additional paid in capital1,2381,2111,1851,1461,1371,1221,076
Accumulated other comprehensive loss      (0)
Accumulated deficit(1,194)(1,192)(1,179)(1,194)(1,140)(1,119)(1,081)
Warrants and rights outstanding     3270
Other undisclosed stockholders' equity attributable to parent     (32)(70)
Total stockholders' equity:44196(47)(2)3(4)
TOTAL LIABILITIES AND EQUITY:966445297590135

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenue, net536551936
Gross profit:185536551935
Operating expenses(22)(22)(36)(67)(95)(101)(94)
Operating income (loss):(4)(17)17(62)(40)(82)(58)
Nonoperating income (expense)441264(0)
Foreign currency transaction gain, before tax     2 
Other nonoperating income (expense)441262(0)
Interest and debt expense(2)(1)(2)(4)(4)(4)(5)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes     43(61)
Income (loss) from continuing operations before equity method investments, income taxes:(2)(13)16(64)(38)(38)(124)
Other undisclosed income from continuing operations before income taxes    18  
Income (loss) from continuing operations before income taxes:(2)(13)16(64)(21)(38)(124)
Income tax expense (benefit) 0(2)   0
Net income (loss):(2)(13)15(64)(21)(38)(124)
Other undisclosed net income attributable to parent   10   
Net income (loss) attributable to parent:(2)(13)15(54)(21)(38)(124)
Undistributed earnings (loss) allocated to participating securities, basic  (3)
Other undisclosed net loss available to common stockholders, basic  (6)    
Net income (loss) available to common stockholders, basic:(2)(13)6(54)(21)(38)(124)
Other undisclosed net income (loss) available to common stockholders, diluted  0  (40) 
Net income (loss) available to common stockholders, diluted:(2)(13)6(54)(21)(78)(124)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(2)(13)15(64)(21)(38)(124)
Comprehensive income (loss):(2)(13)15(64)(21)(38)(124)
Other undisclosed comprehensive income, net of tax, attributable to parent     38124
Comprehensive income (loss), net of tax, attributable to parent:(2)(13)15(64)(21)0(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: